• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普罗帕酮对映体与人类α1-酸性糖蛋白的相互作用。

Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein.

作者信息

Oravcová J, Lindner W, Szalay P, Bohácik L, Trnovec T

机构信息

Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Czechoslovakia.

出版信息

Chirality. 1991;3(1):30-4. doi: 10.1002/chir.530030107.

DOI:10.1002/chir.530030107
PMID:2039682
Abstract

The interaction of propafenone enantiomers with human alpha 1-acid glycoprotein was studied using high-performance liquid chromatography. Each of the two optical antipodes interacted with one class of high-affinity binding sites characterized by Ka(R) = (6.18 +/- 0.93) x 10(5) M-1, n(R) = 1.34 +/- 0.09 for the (R)-isomer and Ka(S) = (8.93 +/- 1.82) x 10(5) M-1, n(S) = 0.99 +/- 0.08 for the (S)-isomer. Nonspecific binding to secondary low-affinity high-capacity binding site(s) was only slightly greater in the case of the (S)-enantiomer (n'k'(S) = (1.06 +/- 0.09) x 10(4) M-1) compared to the (R)-enantiomer (n'k'(R) = (6.87 +/- 0.72) x 10(3) M-1). It was concluded that both enantiomers interact with common single class of high-affinity binding sites on AAG (along with nonspecific binding) exhibiting only slight stereoselectivity for propafenone.

摘要

使用高效液相色谱法研究了普罗帕酮对映体与人类α1-酸性糖蛋白的相互作用。两种光学对映体中的每一种都与一类高亲和力结合位点相互作用,其特征在于,对于(R)-异构体,Ka(R)=(6.18±0.93)×10⁵ M⁻¹,n(R)= 1.34±0.09;对于(S)-异构体,Ka(S)=(8.93±1.82)×10⁵ M⁻¹,n(S)= 0.99±0.08。与(R)-对映体(n'k'(R)=(6.87±0.72)×10³ M⁻¹)相比,(S)-对映体与二级低亲和力高容量结合位点的非特异性结合仅略高(n'k'(S)=(1.06±0.09)×10⁴ M⁻¹)。得出的结论是,两种对映体都与AAG上常见的单一高亲和力结合位点相互作用(以及非特异性结合),对普罗帕酮仅表现出轻微的立体选择性。

相似文献

1
Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein.普罗帕酮对映体与人类α1-酸性糖蛋白的相互作用。
Chirality. 1991;3(1):30-4. doi: 10.1002/chir.530030107.
2
Enantioselective plasma protein binding of propafenone: mechanism, drug interaction, and species difference.普罗帕酮对映体选择性血浆蛋白结合:机制、药物相互作用及种属差异。
Chirality. 2009 Jul;21(7):692-8. doi: 10.1002/chir.20666.
3
Stereoselective binding of isradipine to human plasma proteins.伊拉地平与人血浆蛋白的立体选择性结合。
Chirality. 1995;7(3):167-72. doi: 10.1002/chir.530070311.
4
Interaction of pirprofen enantiomers with human serum albumin.吡洛芬对映体与人血清白蛋白的相互作用。
Chirality. 1991;3(5):412-7. doi: 10.1002/chir.530030506.
5
Binding study of semotiadil and levosemotiadil with alpha(1)-acid glycoprotein using high-performance frontal analysis.使用高效前沿分析法研究塞莫替地尔和左塞莫替地尔与α1-酸性糖蛋白的结合
Anal Biochem. 1999 Oct 1;274(1):27-33. doi: 10.1006/abio.1999.4266.
6
Enantioselective analysis of R- and S-propafenone in plasma by HPLC applying column switching and liquid-liquid extraction.
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3489-94. doi: 10.1016/j.jchromb.2009.08.024. Epub 2009 Aug 21.
7
Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.布比卡因与人血清蛋白、分离的白蛋白和分离的α-1-酸性糖蛋白的结合。两种对映体之间的差异部分归因于协同作用。
J Pharmacol Exp Ther. 1996 Jan;276(1):109-15.
8
Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin.布洛芬与人血清白蛋白结合中的立体选择性及对映体-对映体相互作用
Chirality. 1997;9(7):643-9. doi: 10.1002/(SICI)1520-636X(1997)9:7<643::AID-CHIR1>3.0.CO;2-8.
9
Enantioselective gallopamil protein binding.维拉帕米对映体的蛋白质结合
Chirality. 1993;5(6):414-8. doi: 10.1002/chir.530050604.
10
Concentration dependent stereoselectivity of propafenone N-depropylation metabolism with human hepatic recombinant CYP1A2.普罗帕酮N-去丙基代谢与人肝重组CYP1A2的浓度依赖性立体选择性
Pharmazie. 2003 Sep;58(9):651-3.

引用本文的文献

1
Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.药物血浆和组织结合的测定方法。药代动力学后果。
Clin Pharmacokinet. 1992 Dec;23(6):449-68. doi: 10.2165/00003088-199223060-00005.